Drugs in the pipeline: new therapies that could change treatment strategies
...n cancers and lymphoma.
A Multidisciplinary Phase II Study of azd2171
(cediranib), an Oral Pan-VEGF Receptor Tyrosine Kinase Inhibitor, in Patien...s with Recurrent Glioblastoma: Abstract LB-247
The investigational drug azd2171
(cediranib) may help shrink tumors and prolong survival of patients with a ...
Scientists Developing New Drug To Treat Bowel Cancer
... Experimental studies on mice with a drug called azd2171
which reduced the size and number of polyps in mice have led to the hope // that it could someday soon be used in humans with bowel cancer.